卵巢癌病变隐匿,具有早期扩散的生物学行为,且缺乏简便易行、特异的早期诊断方法,约70%的患者确诊时已属晚期(Ⅲ~Ⅳ期)[1]。目前标准治疗方案是以手术为主、辅以术后化疗、放疗和生物治疗的综合方案。晚期卵巢癌由于肿瘤细胞的广泛播散转移、病灶巨大固定以及邻近组织的严重浸润,相关报道显示仅有42%的患者能行满意的 Ovarian cancer occult lesions, with early proliferation of biological behavior, and the lack of simple, specific and early diagnosis, about 70% of the patients are already diagnosed late (Ⅲ ~ Ⅳ) [1]. The current standard treatment is based on surgery, combined with postoperative chemotherapy, radiotherapy and biological treatment of integrated programs. Advanced ovarian cancer due to the spread of widely disseminated tumor cells, the huge fixed lesions and adjacent infiltration of severe tissue, the relevant reports showed that only 42% of patients can be satisfied